Population
EV71 particles and 6-day-old mouse model of lethal EV71 infection
Comparison
Monoclonal antibody D5, administered as a single… vs PBS or irrelevant monoclonal antibody 3F5
Design
Preclinical
Follow-up
14 days (in mouse model)
Authors
Loading...
May support mAb D5 development for EV71; leaves open human translation and trials.
The broadly neutralizing monoclonal antibody D5 protects against lethal EV71 infection in mice by bivalently binding the highly conserved VP1 GH-loop, providing a structural basis for potential anti-EV71 therapeutics.
Ye et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: